DUBLIN–(BUSINESS WIRE)–The “Extracellular Vesicles & Nanoparticle-based Therapeutics Europe 2023” conference has been added to ResearchAndMarkets.com’s offering.
Welcome to the Extracellular Vesicles (EV) & Nanoparticle-based Therapeutics Europe 2023 Conference to be held 13-14 November 2023 at the Hilton Rotterdam, The Netherlands.
This conference brings together the innovations in Exosomes-EV Research and Nanoparticles and the Therapeutic Opportunities that are Expanding in this space, circa 2023 and bring the key opinion leaders and thought leaders in the field from across Europe and around the world for two intensive days of scientific presentations, networking as well as engagement with companies developing innovations in tools and technologies in this expanding field.
At this conference we bring together speaking faculty who represent academic thought leaders as well as leading industry participants translating technologies into commercial offerings and innovations in the field.
This conference features scientific presentations, industry technology spotlight presentations, posters as well as a co-located exhibition, and the conference features companies in this field developing technologies, products and services as well as moving (clinical) candidates forward into the clinical trials regimen.
The conference features extensive networking opportunities and is held 7-minutes walk from Rotterdam Centraal with fast and very easy access to Amsterdam-Schiphol with worldwide connections as well as the Eurostar to London plus fast-trains to Antwerp, Brussels and Paris.
The Conference is Chaired by Leaders in the Field:
Professor Dr. Raymond Schiffelers, Professor of Nanomedicine, University Medical Center Utrecht
Professor Dr. Dominique PV de Kleijn, Professor Experimental Vascular Surgery; Professor Netherlands Heart Institute, University Medical Center Utrecht
Animal Models for Studying Extracellular Vesicles for Therapeutics, Drug Delivery
Engineered EVs and Engineered Nanoparticles – Features, Benefits and Therapeutic Applications
Expression and Deployment of Biologics from Extracellular Vesicles (EV) for Therapeutics Applications
Extracellular Vesicles (EVs): Therapeutic and Drug Delivery Potential
Extracellular Vesicles and MSCs
An Emerging Area of Investigation for Regenerative Medicine
Nanoparticles as Delivery Vehicles
Biologics – Engineered Nanoparticles for Drug Delivery
Vaccines – Technologies for Engineering EVs for Therapeutics, Drug Delivery Vehicles, Biologics
Raymond Schiffelers – Professor of Nanomedicine, University Medical Center Utrecht
Dominique PV de Kleijn – Professor Experimental Vascular Surgery; Professor Netherlands Heart Institute, University Medical Center Utrecht
Mario Gimona – Head of Manufacturing, GMP Unit, Paracelsus Medical University Salzburg
Alain Brisson – Professor Emeritus, University of Bordeaux
Eva Rohde – Head of Department for Transfusion Medicine, Director of GMP Laboratory, Paracelsus Medical University Salzburg
Sai Kiang Lim – Research Director, Institute of Medical Biology, A*STAR
Bernd Giebel – Group Leader, Institute for Transfusion Medicine, University Hospital Duisburg-Essen
Samir EL-Andaloussi – Associate Professor, Karolinska Institutet
For more information about this conference visit https://www.researchandmarkets.com/r/mufyhh
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Thank you for donating to DutchNews.nl.
We could not provide the Dutch News service, and keep it free of charge, without the generous support of our readers. Your donations allow us to report on issues you tell us matter, and provide you with a summary of the most important Dutch news each day.Make a donation